Ran Nussbaum - Jun 16, 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Jun 16, 2022
Transactions value $
$11,055
Form type
4
Date filed
2/28/2023, 11:21 AM
Previous filing
Jun 17, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise $11.1K +2.21K +0.15% $5.00* 1.44M Jun 16, 2022 Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Options Exercise $0 -2.21K -100% $0.00* 0 Jun 16, 2022 Ordinary Shares 2.21K $5.00 By Pontifax (Israel) III Limited Partnership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.